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Abstract
Background: Nikkomycins are a group of peptidyl nucleoside antibiotics produced by Streptomyces
ansochromogenes. They are competitive inhibitors of chitin synthase and show potent fungicidal, insecticidal, and
acaricidal activities. Nikkomycin X and Z are the main components produced by S. ansochromogenes. Generation of
a high-producing strain is crucial to scale up nikkomycins production for further clinical trials.
Results: To increase the yields of nikkomycins, an additional copy of nikkomycin biosynthetic gene cluster (35 kb)
was introduced into nikkomycin producing strain, S. ansochromogenes 7100. The gene cluster was first reassembled
into an integrative plasmid by Red/ET technology combining with classic cloning methods and then the resulting
plasmid(pNIK)was introduced into S. ansochromogenes by conjugal transfer. Introduction of pNIK led to enhanced
production of nikkomycins (880 mg L
-1, 4 -fold nikkomycin X and 210 mg L
-1, 1.8-fold nikkomycin Z) in the
resulting exconjugants comparing with the parent strain (220 mg L
-1 nikkomycin X and 120 mg L
-1 nikkomycin Z).
The exconjugants are genetically stable in the absence of antibiotic resistance selection pressure.
Conclusion: A high nikkomycins producing strain (1100 mg L
-1 nikkomycins) was obtained by introduction of an
extra nikkomycin biosynthetic gene cluster into the genome of S. ansochromogenes. The strategies presented here
could be applicable to other bacteria to improve the yields of secondary metabolites.
Introduction
Actinomycetes produce a wide variety of secondary
metabolites, including antibacterial antibiotics, anticancer
agents and immunosuppressive agents. Traditionally, the
improvement of antibiotic-producing strain suitable for
industrial fermentations is achieved by random mutagen-
esis and selection techniques. Although these techniques
have succeeded in generating many industrial strains, it
exhausted time and human resources. Overexpression of
positive transcriptional regulators of a biosynthetic clus-
ter or specific enzymes involving in metabolic bottle-
necks has significantly overproduced a variety of natural
products [1]. Whereas more than a single rate-limiting
step often exists in the biosynthetic pathway of secondary
metabolites [2], overexpression of the entire antibiotic
biosynthetic gene cluster may possibly improve the yields
of the desired natural product further.
The positive contribution of amplification of biosyn-
thetic gene clusters to antibiotics production have been
previously observed in some industrial overproducing
strains [3-5]. For instance, in the kanamycin-overprodu-
cing strain, Streptomyces kanamyceticus 12-6 which was
generated by classical mutagenesis, tandem amplification
of the entire kanamycin (Km) biosynthetic gene cluster
was disclosed to directly contribute to Km overproduc-
tion and the level of Km production depended on the
copy number of the Km biosynthetic gene cluster[5].
This provides a hint that introduction of extra copy of
biosynthetic gene cluster into parent strain may be an
effective and widespread approach to improve the pro-
duction of antibiotics. However, the antibiotic biosyn-
thetic gene cluster consisting of structural and
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difficult to identify multiple unique restriction sties and
circularize large vectors. So, few reports were related to
overexpression of the whole biosynthetic gene cluster in
parent strain using directed genetic approaches.
Recently, the development of Red/ET technology
enabled an alternative means of restriction/ligation-free
gene manipulation of the large biosynthetic gene clus-
ters. Red/ET technology is based on the discovery that
in engineered E. coli containing Reda,R e d b,a n dR e d g
proteins from the l phage or RecE/RecT from the Rac
phage, allelic exchanges can take place if a given DNA
fragment is flanked at both ends by extensions of only a
few tens of nucleotides that are homologous to a target
DNA region [6,7]. Red/ET technology has become an
efficient approach to cloning and modifying whole bio-
synthetic gene clusters. Biosynthetic gene clusters of
myxochromide S (~30 kb) [8], myxothiazole (~60 kb)
[9], coumermycin A1 (~38 kb) [10], phenalinolactone
(~42 kb) [11], anthramycin (~32 kb) [12] and epothilone
(~60 kb) [13] have been successfully constructed by dif-
ferent strategies based on Red/ET technology and het-
erologously expressed in different strains.
Nikkomycins are a group of peptidyl nucleoside anti-
biotics with potent fungicidal, insecticidal, and acaricidal
activities. They are recognized as ideal fungicide and
medications for human being by virtue of its nontoxic to
mammals and bees, and easily degradable in nature [14].
Nikkomycin X and Z (Fig. 1A), the main components
produced by S. ansochromogenes, consist of hydoxypyri-
dylhomethreonine (nikkomycin D) and a 5-aminohexuro-
nic acid N-glucosidically bound to uracil in nikkomycin Z
or to 4-formyl-4-imidazolin-2-one (imidazolone) in nik-
komycin X. The genes involving in nikkomycin biosynth-
esis have been identified and the coding regions
responsible for the biosynthesis of nikkomycins spanned
about 35 kb on the chromosome of S. ansochromogenes
and organized in the three transcriptional units [15,16].
In this work, we report application of Red/ET technol-
ogy combined with classic cloning procedures to con-
struct the whole nikkomycin biosynthetic gene cluster in
an integrative plasmid, and investigate the effect of
duplication of the entire gene cluster on nikkomycins
production in S. ansochromogenes and assess the stabi-
lity of the engineered nikkomycin producer.
Results
Reassembling of the nikkomycin biosynthetic gene
cluster by Red/ET
Our previous studies showed that sanG and sanX were
indispensable for nikkomycin biosynthesis and their dis-
ruption led to the abolishment of nikkomycin produc-
tion [17,18], whereas deletion of a 8 kb upstream of
sanG or 3 kb downstream of sanX did not affect
nikkomycin production (data not shown). These results
suggest that sanG is at the left boundary of the nikko-
mycin cluster and sanX is at the right boundary. To
obtain the nikkomycin biosynthetic gene cluster, a cos-
mid library of genomic DNA from S. ansocrhomogenes
7100 was constructed and screened by PCR. A cosmid
named cosG4 containing most of the genes involving in
nikkomycin biosynthesis was obtained. It harbored DNA
sequences ranging from 8 kb upstream of sanG to sanC
and partial sanDE, whereas intact sanDE and sanX,
which were also essential for nikkomycin biosynthesis,
were not located on cosG4 (Fig. 1B). pLXP, a plasmid
based on pSET152, had an 11 kb insertional sequence
containing the partial sanI and complete sanF, sanA,
sanB, sanC, sanDE, sanX and 3 kb downstream of sanX
[18]. cosG4 and pLXP harbored 6 kb overlapping
regions, which enabled the use of Red/ET recombination
to reassemble both parts to construct the nikkomycin
biosynthetic gene cluster (NIK gene cluster).
Figure 1 Chemical structures of nikkomycin X and Z and
strategy for reassembling the entire nikkomycin gene cluster
in an integrative plasmid. (A) Chemical structures of nikkomycin X
and Z. (B) Construction of the nikkomycin biosynthetic gene cluster.
The nikkomycin biosynthetic gene cluster consists of 22 ORFs (sanG-
sanX) and is located on a supercos 1 based cosmid cosG4 and a
pSET152 based plasmid pLXP. cosG4 contains most of the
biosynthetic genes ranging from 8 kb DNA fragment upstream of
sanG to partial sanDE; pLXP contains several biosynthetic genes
ranging from partial sanI to 3 kb downstream of sanX.A6k b
overlapping fragment between cosG4 and pLXP could be used as
the lower recombinant arm. The upper arm was generated by
insertion of a 4.5 kb DNA fragment from the upstream region of
sanG into the pLXP to give pLXP-NRPS. The resulting pLXP-NRPS
was linearized and then used to reassemble the whole cluster by
Red/ET recombination with cosG4. The final construct containing
the complete nikkomycin biosynthetic gene cluster was designated
pNIK.
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mid was performed as described in the section of Mate-
rials and Methods(Fig. 1B)and the final construct was
designated as pNIK. The identity of pNIK was further
confirmed through PCR and restrictive analysis (Fig. 2).
Duplication of the NIK gene cluster in S.
ansochromogenes 7100
pNIK was passed through E. coli ET12567/pUZ8002 and
then introduced into S. ansochromogenes 7100 by conju-
gal transfer according to established techniques. The
resulting transformants were inoculated on MS plates in
the presence of apramycin to form spores. Gray spores
were harvested and transferred into liquid medium.
Three apramycin-resistant transformants were obtained
and all of them led to an improved nikkomycin production
ranging from 4-fold to 5-fold (Fig. 3). As control, introduc-
tion of pSET152 into the chromosome of S. ansochromo-
genes had no effect on nikkomycin production (data not
shown). One of the tranformants, designated DNik, was
chosen for further investigation. To verify the integration
of pNIK into the genome of S. ansochromogenes, genomic
DNA of S. ansochromogenes 7100, S. ansochromogenes
7100 (pSET152) and DNik was isolated and used as tem-
plate to perform PCR. A 964 bp of DNA fragment was
amplified from genomic DNA of S. ansochromogenes 7100
(pSET152) and DNik, but not from S. ansochromogenes
7100 (Fig. 4), demonstrating that pNIK integrated at the
attB s i t ei nt h eg e n o m eo fS. ansochromogenes.T h eS.
ansochromogenes 7100 (pSET152) and DNik had compar-
able growth rates and final biomass (Fig. 5A), indicating
that higher biomass was not an overproduction mechan-
ism of DNik. DNik showed higher nikkomycins produc-
tion than S. ansochromogenes 7100 (pSET152) after
incubation for 2 days, and 4.3-fold (1100 mg/L) much
higher production after 5 days (Fig. 5B). Furthermore,
introduction of pNIK into S. ansochromogenes 7100 had
different effect on the yields of nikkomycin X and nikko-
mycin Z, leading to 4-fold (880 mg/L) improvement of
nikkomycin X production and 1.8-fold (220 mg/L) of nik-
komycin Z (Fig. 5C and 5D).
To investigate the stability of DNik, the mutant was
incubated in the absence of apramycin. After 5 passages,
10 colonies were randomly selected and cultured in the
presence of apramycin for 5 days. All of them still con-
ferred apramycin resistance and produced approximately
4.2-fold of yields of nikkomycins compared with the
parent strain (data not shown). These results demon-
strated that the transformants harboring one extra copy
of NIK gene cluster are genetically stable in S.
ansochromogenes.
Discussion
Duplication of biosynthetic gene clusters to increase the
yields of secondary metabolites had been applied using
directed genetic approaches. In fungi, introduction of
the whole biosynthetic gene cluster of penicillin into
penicillin producing strain Penicillium chysogenum
Wis54-1255 and that of compactin into P. citrinum
resulted in significantly increased production of
Figure 2 PCR and restriction analysis of pNIK.( A )D i g e s t i o no f
pLXP, cosG4 and pNIK with EcoRI, BamHI and KpnI. pNIK contained
the same restriction fragments with pLXP and cosG4 and generated
some new ones. M, 1 kb molecular marker; lane 1, 4 and 7, pLXP;
lane 2, 5 and 8, cosG4; lane 3, 6 and 9, pNIK. (B) PCR analysis of
pLXP, cosG4 and pNIK. pNIK contained all three genes tested.
Primers sanP+, sanP-, sanX+, sanX-, sanF+ and sanF- were used to
amplify a 400 bp, 220 bp and 120 bp DNA fragment of sanP, sanX
and sanF using pLXP, cosG4 and pNIK as template. M, 100 bp
molecular marker, lane 1, 4 and 7, cosG4; lane 2, 5 and 8, pLXP; lane
3, 6 and 9, pNIK.
Figure 3 HPLC analysis of Nikkomycins production in S.
ansochromogenes and its derivatives. (A) S. ansochromogenes
7100 (pSET152); (B) DNik. The strains were inoculated in liquid SP
medium for 120 h. X, nikkomycin X; Z, nikkomycin Z.
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myces, when the whole gene cluster of cephamycin C
from S. cattleya was introduced into another cephamy-
cin producer, S. lactamgens,a2t o3 - f o l di m p r o v e m e n t
in titer was achieved [21]. However, in these cases, cos-
mids were applied to load the antibiotic gene clusters.
Isolation of an intact biosynthetic gene cluster onto a
single comsid was extremely difficult owing to its large
size. Instead, construction of the whole biosynthetic
gene cluster from several cosmids or plasmids which
contained partial DNA fragments of the cluster was
more feasible and the development of Red/ET technol-
ogy facilitated this procedure. In this work, we employed
Red/ET technology to reassemble the entire NIK cluster
in an integrative vector, pSET152, which potentially
allowed the resulting nikkomycin overproducer with
genetic stability and demons t r a t e dp o s i t i v ee f f e c to f
introduction of NIK cluster into the parent strain on
nikkomycins production. Our results were consistent
with other groups’ similar results, showing that duplica-
tion of NIK cluster could significantly improve the yields
of nikkomycins.
It is common that high-producing strains containing a
self-replicating plasmid or cosmid usually lose their high
Figure 4 PCR analysis of the integration of pNIK into the
genome of S. ansochromogenes. (A) M, 100 bp marker; Lane 1, S.
ansochromogenes 7100; Lane 2, S. ansochromogenes 7100 (pSET152);
Lane 3, S. ansochromogenes DNik. (B) Physical map of pSET152
inserted into the attB site of S. ansochromogenes. Primer test-F and
test-R were used to amplify 964 bp DNA fragment from the
genomic DNA of S. ansochromogenes 7100 (pSET152) and DNik.
Chromosomal DNA is indicated by thin lines, and pSET152 is
indicated by thick lines. int, the integrase gene; aac(3)IV, the
apramycin resistance gene.
Figure 5 Nikkomycins production and biomass of S. ansochromogenes and its derivatives in SP medium. (A) Biomass. S.
ansochromogenes 7100 (pSET152) (open circle), DNik (close circle); (B) Total nikkomycins production; (C) Nikkomycin Z production. S.
ansochromogenes 7100(pSET152) (open square), DNik (close square); (D) Nikkomycin X production. S. ansochromogenes 7100(pSET152) (open
triangle), DNik (close triangle).
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of antibiotic resistance selection pressure [21]. However,
it was impractical to culture strains in large scale in the
presence of antibiotics. pSET152, which could be intro-
duced into Streptomyces by conjugal transfer and stably
integrated into the Streptomyces chromosome by site-
specific recombination at the phage C31 attachment
site (attB) [22], provided an alternative to get stable high-
producing strains. It was feasible to construct the whole
secondary biosynthetic gene cluster using Red/ET tech-
nology into pSET152 or other vectors which contained
the DNA fragments of oriT (RK2) region, the phage
C31 attachment site and integrase gene from pSET152.
As a linear relationship was observed between the cluster
copy number and the yields of antibiotics [3,5], more
copies of the gene cluster could be introduced into the
Streptomyces chromosome using other phage based plas-
mids (e.g. pSAM2, pSOK804 or pRT801), which inte-
grated at sites different from the C31 [23]. Recently,
Tyo and colleagues developed an efficient approach to
increase the copy number of target DNA fragment in E.
coli using chemically inducible chromosomal evolution
(CICHE) [24] and its application in Streptomyces would
facilitate the introduction of more copy of whole biosyn-
thetic gene cluster into the Streptomyces chromosome. It
is noteworthy that the highest nikkomycin production
reported is 3.2 g/L in S. tandae Tü 901/S 2556, which
was subjected to multiple rounds of strain improvement
[25]. Therefore, we expect that introduction of extra
copy of NIK cluster could be a potential strategy for
further increase of nikkomycin production.
Duplication of the whole NIK cluster had different effect
on the nikkomycin X and nikkomycin Z production. Nik-
komycin X and Z had the same peptidyl moiety but differ-
ent nucleoside moiety. Imidazolone, the base of
nikkomycin X, was catalyzed by enzymes encoded by
sanO, sanQ and sanP from S. ansochromogenes [26],
whereas uracil, the base of nikkomycin Z, was synthesized
by de novo synthesis or salvage pathway. Duplication of
the NIK gene cluster may increase the transcription of the
whole transcriptional units, providing more precursors for
biosynthesis of nikkomycin X. However, duplication of the
NIK gene cluster could not significantly increase the pool
of uracil, resulting in a modest increase in nikkomycin Z
production (1.8-fold). These results were consistent with
our previous results that overexpression of sanO could
only increase the yields of nikkomycin X [27].
Conclusion
Development of new techniques and tools for gene
manipulation (e.g. Red/ET recombination) significantly
facilitate cloning and reassembling of antibiotic gene
clusters with large size in a given vector. In this study,
Red/ET approach was applied to reassemble the entire
nikkomycin biosynthetic gene cluster in an integrative
vector, allowing the generation of a stable nikkomycin
overproducer. Our investigation provides an insight that
introduction of the biosynthetic gene cluster into parent
strain could be a simple and widespread approach for
improving the yields of antibiotics of commercial interest.
Materials and methods
Bacterial strains, plasmids and growth conditions
Bacterial strains and plasmids used in this study are
listed in Table 1. S. ansochromogenes 7100, the wild type
producer of nikkomycin (120 mg/L nikkomycin Z and
220 mg/L nikkomycin X), was collected in our labora-
tory. S. ansochromogenes and its derivative strains were
grown at 28°C in different media. Liquid medium YEME
and solid medium MS were prepared as described else-
where[28]. SP medium (3% mannitol, 1% soluble starch,
0.5% soy peptone and 0.8% yeast extract, pH 6.0) was
used for nikkomycins production. E. coli strains were
incubated in LB medium at 37°C or 30°C (for Red/ET
protein expression). When necessary, antibiotics were
used at the following concentrations: apramycin, 10 μg
ml
-1 in YEME or MS for S. ansochromogenes, 100 μg
ml
-1 in LB for E. coli; kanamycin, 10 μgm l
-1 in YEME
or MS for S. ansochromogenes,1 0 0μgm l
-1 in LB for
E. coli and choramphenicol 34 μgm l
-1 in LB for E. coli.
Primers and Polymerase chain reactions
Polymerase chain reactions (PCRs) were performed
using Taq DNA polymerase. sanP+: GCGGCCAGC-
TACTTCCGGGAC, sanP-: GCAGAAAGGCCGAGCG-
CATGT; sanX+: GCAGAAAGGCCGAGCGCATGT,
sanX-: GCTACAGCGGGGCGGTCAAG; sanF+: CAGG
TCGGGGATCAGGGTC, sanF-: GCGGCCAGCTAC
TTCCGGGAC; all of them were used to confirm the
identity of pNIK. An initial denaturation at 95°C for 5
min was followed by 30 cycles of amplification (95°C for
1 min, 60°C for 30 s and 72°C for 1 min) and additional
10 min at 72°C.
Construction of genomic library for S. ansochromogenes
For construction of a cosmid library of S. ansocrhomo-
genes,1 0μg of chromosomal DNA was partially digested
with Sau3AI. The 30-45 kb DNA fragments were isolated
and ligated into supercos 1. After incubation at 16°C for
16 h, the ligated DNA was packaged using Gigapack III
XL packaging kit (Stratagene) and introduced into E. coli
XL-blue MR. The cosmid library was screened by PCR
using primers sanP+ 5’ GCGGCC AGCTACTTCCGG-
GAC 3’ and sanP- 5’ GCAGAAAGG CCGAGCGCATGT
3’. Cosmid (mix) was used as template and the positive
clones were identified in 96-well plates.
Reassembling of the entire nikkomycin biosynthetic gene
cluster by Red/ET
The Red/ET recombination technique was described
previously [6]. In the present study this method was
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thetic gene cluster onto an integrative plasmid.
A4 . 5k bEcoRI-XhoI DNA fragment containing the
upstream region of sanG from cosG4 was inserted into
the same site of pBS-1 to generate pNRPS, and then
digested with XbaI/BamHI. The resulting 4.5 kb DNA
fragment was inserted into the same site of pLXP to
give pLXP-NRPS. Subsequently, pLXP-NRPS was
digested with BamHI, dephosphorated with calf phos-
phatase (Takara, Japan) to generate the two recombinant
arms for Red/ET recombination. The resulting linear
fragment (1 μg) was then introduced into E. coli
BW25113/pIJ790 containing cosmid cosG4 by electro-
poration. The pNIK was selected by apramycin
resistance.
Integration of pNIK into the genome of S.
ansochromogenes
phiC31 integrase in pSET152 can integrate intragenically
into the attB site of SCO3798 of S. coelicolor [29].
SCO3798 is a highly conserved gene in Streptomyces
and its homologue (92% identity) is found in genome of
S. ansochromogenes after whole genome 454 sequencing
(Li, et al, unpublished results). Primer test-F: GGTGT
CGCCGTTGGTGATG and test-R: GGCTTGAAGGGA
AGGTGTTTGT were used to verify the integration of
pSET152 or pNIK into the genome of S.
ansochromogenes.
HPLC analysis of nikkomycins
Spores of S. anchromogenes were inoculated in YEME.
The cultures were grown at 28°C on a rotary shaker
(220 rpm) for 48 h and used as seed cultures. 1 ml
(0.5% V/V) of seed culture was inoculated into flasks
containing 50 ml of SP medium, and then fermented at
28°C on a rotary shaker (200 rpm) for 5 days. The cul-
ture filtrates were harvested by centrifugation and the
supernatant was filtered through a Minipore membrane
(pore diameter 0.2 μm). Nikkomycins were identified by
HPLC analysis (Agilent 1100 HPLC and RPC-18) at 290
nm absorption wavelengths. Chemical reagent, mobile
phase and gradient elution process were as described by
Fiedler [30].
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